Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Wahid B, Shami K, Joiya SA, Ozuyar SEG, et al. Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combinations (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin). J Med Virol 2020 May 17. doi: 10.1002/jmv.25931.
PMID: 32419178


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016